At the annual Empirical meeting, significant progress was shared in the treatment of associated pneumonia in children under one year old with HIV. An international [...]
An international team led by the Global Pediatric Infectious Diseases Innovation Group at the public University Hospital 12 de Octubre, in collaboration with research centers [...]
Certificado participación GESIDACERTIFY THAT: Á. Ballesteros Magán, A. Tagarro, S. Domínguez-Rodríguez, W.C. Buck, V. Musiime, H.A. Mujuru, C. Chabala, J. Sacarlal, D. Nalwanga, T. [...]
Background Super-boosted lopinavir/ritonavir (LPV/r; ratio 4:4 instead of 4:1) is recommended for infants with HIV who are also receiving rifampicin-based tuberculosis (TB) treatment. However, due [...]
Background This study assessed dolutegravir pharmacokinetics in HIV-infected infants receiving twice-daily (BID) dolutegravir with rifampicin-based tuberculosis (TB) treatment compared to once-daily (OD) dolutegravir without rifampicin. [...]